These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Novel form of intermediate salla disease: clinical and neuroimaging features. Morse RP; Kleta R; Alroy J; Gahl WA J Child Neurol; 2005 Oct; 20(10):814-6. PubMed ID: 16417876 [TBL] [Abstract][Full Text] [Related]
5. Biochemical and molecular analyses of infantile free sialic acid storage disease in North American children. Kleta R; Aughton DJ; Rivkin MJ; Huizing M; Strovel E; Anikster Y; Orvisky E; Natowicz M; Krasnewich D; Gahl WA Am J Med Genet A; 2003 Jul; 120A(1):28-33. PubMed ID: 12794688 [TBL] [Abstract][Full Text] [Related]
6. A New Patient With Intermediate Severe Salla Disease With Hypomyelination: A Literature Review for Salla Disease. Barmherzig R; Bullivant G; Cordeiro D; Sinasac DS; Blaser S; Mercimek-Mahmutoglu S Pediatr Neurol; 2017 Sep; 74():87-91.e2. PubMed ID: 28662915 [TBL] [Abstract][Full Text] [Related]
7. Studies on the defect underlying the lysosomal storage of sialic acid in Salla disease. Lysosomal accumulation of sialic acid formed from N-acetyl-mannosamine or derived from low density lipoprotein in cultured mutant fibroblasts. Renlund M; Kovanen PT; Raivio KO; Aula P; Gahmberg CG; Ehnholm C J Clin Invest; 1986 Feb; 77(2):568-74. PubMed ID: 3944269 [TBL] [Abstract][Full Text] [Related]
9. Salla disease in Turkish children: severe and conventional type. Coker M; Kalkan-Uçar S; Kitiş O; Uçar H; Gökşen-Simşek D; Darcan S; Gökben S Turk J Pediatr; 2009; 51(6):605-9. PubMed ID: 20196397 [TBL] [Abstract][Full Text] [Related]
10. Renal handling of free sialic acid in normal humans and patients with Salla disease or renal disease. Seppala R; Renlund M; Bernardini I; Tietze F; Gahl WA Lab Invest; 1990 Aug; 63(2):197-203. PubMed ID: 2381164 [TBL] [Abstract][Full Text] [Related]
11. Quantification of free sialic acid in urine by HPLC-electrospray tandem mass spectrometry: a tool for the diagnosis of sialic acid storage disease. Valianpour F; Abeling NG; Duran M; Huijmans JG; Kulik W Clin Chem; 2004 Feb; 50(2):403-9. PubMed ID: 14684624 [TBL] [Abstract][Full Text] [Related]
12. Studies of lysosomal sialic acid metabolism: retention of sialic acid by Salla disease lysosomes. Jonas AJ Biochem Biophys Res Commun; 1986 May; 137(1):175-81. PubMed ID: 3718508 [TBL] [Abstract][Full Text] [Related]
13. Homozygosity for the p.K136E mutation in the SLC17A5 gene as cause of an Italian severe Salla disease. Biancheri R; Rossi A; Verbeek HA; Schot R; Corsolini F; Assereto S; Mancini GM; Verheijen FW; Minetti C; Filocamo M Neurogenetics; 2005 Dec; 6(4):195-9. PubMed ID: 16170568 [TBL] [Abstract][Full Text] [Related]
14. A case of Salla disease with involvement of the cerebellar white matter. Linnankivi T; Lönnqvist T; Autti T Neuroradiology; 2003 Feb; 45(2):107-9. PubMed ID: 12592494 [TBL] [Abstract][Full Text] [Related]
16. [Lysosomal membrane transport disorders--cystinosis and sialic acid storage disorders (Salla disease, ISSD)]. Yano T; Ohno K Nihon Rinsho; 1995 Dec; 53(12):3068-71. PubMed ID: 8577060 [TBL] [Abstract][Full Text] [Related]
17. Free N-acetylneuraminic acid in tissues in Salla disease and the enzymes involved in its metabolism. Renlund M; Chester MA; Lundblad A; Parkkinen J; Krusius T Eur J Biochem; 1983 Jan; 130(1):39-45. PubMed ID: 6297896 [TBL] [Abstract][Full Text] [Related]
18. Quantification of free and total sialic acid excretion by LC-MS/MS. van der Ham M; Prinsen BH; Huijmans JG; Abeling NG; Dorland B; Berger R; de Koning TJ; de Sain-van der Velden MG J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):251-7. PubMed ID: 17123874 [TBL] [Abstract][Full Text] [Related]